戻る Agenda
Session 1: Keynote Address: Innovative Therapies, Processes and the Growing Role for Pharmacovigilance
Session Chair(s)
William Gregory, PHD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
Stella Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP
Strategy
Consultant, United Kingdom
Session Chair
Speaker(s)
James Wabby, MHS
AbbVie, United States
Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
Keynote Speaker
Hans-Georg Eichler, MD, MSC
Austrian Association of Social Security Bodies, Austria
Consulting Physician